Redeye comments on Ortoma’s agreement with DePuy Synthes. The groundbreaking agreement includes an initial payment of USD750,000, which Ortoma receives directly, and the potential to achieve significant milestones totalling USD8.2m. Redeye argues that the agreement is pivotal for Ortoma, opening doors to key markets such as the US and EU for OTS™ Hip.
LÄS MER